Renaissance Technologies - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96
-92.3%
30,282
-88.0%
0.00%
-100.0%
Q2 2023$1,252
-40.9%
251,900
-41.2%
0.00%
-33.3%
Q1 2023$2,118
-23.5%
428,700
-2.6%
0.00%
-25.0%
Q4 2022$2,768
-100.0%
440,100
-54.8%
0.00%
-60.0%
Q1 2022$8,880,000
-51.7%
974,700
+38.4%
0.01%
-56.5%
Q2 2021$18,371,000
+480.6%
704,400
+739.6%
0.02%
+666.7%
Q3 2020$3,164,000
+193.2%
83,900
+232.9%
0.00%
+200.0%
Q2 2020$1,079,00025,2000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders